Endoscopic gastric remodeling procedures for obesity treatment: a comprehensive review
Stephen Ka Kei Ng , Philip Wai Yan Chiu
Metabolism and Target Organ Damage ›› 2025, Vol. 5 ›› Issue (3) : 34
Obesity has become a global epidemic, posing significant health challenges for individuals and straining healthcare systems worldwide. Endoscopic bariatric and metabolic therapies have emerged as an evolving field, characterized by their minimally invasive, reversible, and organ-preserving nature. This modality offers a promising alternative to traditional bariatric surgery. Various endoscopic therapies targeting the stomach and small bowel have been developed. Among these, endoscopic gastric remodeling interventions have demonstrated superior effectiveness and durability. These procedures utilize endoscopic tissue approximation devices to perform full-thickness suturing or plication of the gastric wall, thereby restricting the stomach volume and altering gastric motility to induce early satiety. This review aims to provide a comprehensive summary of the different endoscopic gastric remodeling interventions and discuss potential future developments in this rapidly evolving field, which holds the promise of offering an alternative therapeutic approach to the management of the global obesity epidemic.
Endoscopic gastric remodeling / endoscopic sleeve gastroplasty / primary obesity surgery endoluminal / endomina / obesity / bariatric endoscopy / endoscopic bariatric / metabolic therapy
| [1] |
|
| [2] |
World obesity. World obesity atlas 2023. Available from: https://www.worldobesity.org/resources/resource-library/world-obesity-atlas-2023. [Last accessed on 7 Jul 2025]. |
| [3] |
|
| [4] |
in adult body-mass index in 200 countries from 1975 to 2014: a pooled analysis of 1698 population-based measurement studies with 19·2 million participants.The Lancet2016;387:1377-96 PMCID:PMC7615134 |
| [5] |
|
| [6] |
|
| [7] |
|
| [8] |
|
| [9] |
|
| [10] |
|
| [11] |
|
| [12] |
|
| [13] |
|
| [14] |
|
| [15] |
|
| [16] |
|
| [17] |
|
| [18] |
|
| [19] |
|
| [20] |
|
| [21] |
|
| [22] |
|
| [23] |
Dayyeh BK, Rajan E, Gostout CJ. Endoscopic sleeve gastroplasty: a potential endoscopic alternative to surgical sleeve gastrectomy for treatment of obesity.Gastrointest Endosc2013;78:530-5 |
| [24] |
|
| [25] |
|
| [26] |
|
| [27] |
|
| [28] |
|
| [29] |
|
| [30] |
|
| [31] |
|
| [32] |
|
| [33] |
|
| [34] |
|
| [35] |
|
| [36] |
|
| [37] |
|
| [38] |
|
| [39] |
|
| [40] |
|
| [41] |
|
| [42] |
|
| [43] |
|
| [44] |
|
| [45] |
|
| [46] |
|
| [47] |
|
| [48] |
|
| [49] |
|
| [50] |
|
| [51] |
|
| [52] |
|
| [53] |
|
| [54] |
|
| [55] |
|
| [56] |
|
| [57] |
|
| [58] |
|
| [59] |
|
| [60] |
|
| [61] |
|
| [62] |
|
| [63] |
|
| [64] |
|
| [65] |
|
| [66] |
|
| [67] |
|
| [68] |
|
| [69] |
|
| [70] |
|
| [71] |
|
| [72] |
|
| [73] |
Rubino D, Abrahamsson N, Davies M, et al; STEP 4 Investigators. Effect of continued weekly subcutaneous semaglutide vs placebo on weight loss maintenance in adults with overweight or obesity: the STEP 4 randomized clinical trial. JAMA. 2021;325:1414. PMCID:PMC7905697 |
| [74] |
|
| [75] |
|
| [76] |
Ifso Registry. The 8th IFSO Global Registry Report. Available from: https://www.ifso.com/ifso-registry.php. [Last accessed on 7 Jul 2025]. |
| [77] |
|
| [78] |
|
| [79] |
|
| [80] |
|
| [81] |
|
| [82] |
|
| [83] |
|
| [84] |
|
| [85] |
|
| [86] |
|
| [87] |
|
| [88] |
|
| [89] |
|
| [90] |
|
| [91] |
|
| [92] |
|
| [93] |
|
| [94] |
|
| [95] |
Khatry M, Abu Dayyeh BK. The primary obesity surgery endoluminal 2.0 enfolding technique (POSE 2.0et): modification to enhance efficiency and increase restriction.OBES SURG2023;33:1953-4 |
| [96] |
|
| [97] |
|
| [98] |
|
/
| 〈 |
|
〉 |